Rich Pharmaceuticals, Inc.'s new division, CannCodex, announced the appointment of Justin Braune as member of the CannCodex Advisory Board. In his capacity on the Advisory Board, Justin Braune will add significant value to the company's planned CannCodex subsidiary with his deep industry experience and extensive contacts. He will be directly involved in the development of CannCodex to guide its development which is expected to be one of the most sought out databases within the industry. Justin Braune brings with him years of public company experience and understanding of the industry landscape. Currently serving as a founding Chairman of the Cannabis LAB, Los Angeles chapter, he sits with one of the most esteemed groups within the industry.